Canadian Healthcare Technology Logo
  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us

GE Revolution Ascend

GE Revolution Ascend

Enovacom EPC

Enovacom EPC

COVID-19

Infectious disease companies announce partnership

March 23, 2022


Michael SoligoTORONTO – ParticleOne has become the first platform of its kind to integrate with BlueDot, the infectious disease intelligence system. The combined use of the two platforms expands their tools and accelerates their response capabilities.

Developed by Canadian environmental engineering firm RWDI, ParticleOne is cloud-based software that measures, models, and reduces the risk of viral transmission within a specified shared space.

“The fast pace of COVID and its variants confirms that we need faster insights to better prepare. There is often no time to wait for updated government guidelines. The ParticleOne/BlueDot partnership provides our clients with the advantage of speed and accuracy to prepare and implement the right measures, for whatever the next threat may be,” said Michael J. Soligo (pictured), CEO, ParticleOne and RWDI

Among the first to identify the emerging risk of COVID-19, the BlueDot intelligence platform provides insights through data and analytics. Powered by human and machine learning, BlueDot enables scientists, analysts, and advisors to gain a deeper understanding of emerging threats and the dynamics of infectious diseases.

“Our partnership with RWDI to bolster their ParticleOne platform with BlueDot infectious disease intelligence unlocks an important step forward on our shared mission. We look forward to providing our integrated solution to public and private organizations reopening everywhere,” said Dr. Kamran Khan, founder and CEO, BlueDot.

The ParticleOne platform powered by BlueDot intelligence provides enterprises and governments with advanced warnings on emerging threats, as well as guidance on specific risks and how to respond to those risks effectively.

BlueDot intelligence answers the questions of what viral threats are coming and ParticleOne answers building operators’ questions of what to do now. Together, the platforms enable confident, science-driven decision-making sooner.

ParticleOne and BlueDot empower decision-makers with the ability to make quantitative decisions to protect people, operations, and revenue sooner. From facilities managers managing HVAC systems to HR directors implementing screening policies, the enhanced platform delivers an unrivaled level of data-driven value in field.

As Canadian technology pioneers with international clients, the strategic partnership between ParticleOne and BlueDot brings together world leaders in infectious disease and the potential for the first comprehensive outbreak management platform in a post-COVID-19 world.

About BlueDot
Founded in 2013, BlueDot provides analysts and data scientists with the foresight to detect, assess, and respond to infectious diseases. BlueDot intelligence empowers governments and enterprises to act sooner with confidence, and significantly improve their agility and resilience. Used by private and public sector organizations, including the Public Health Agency of Canada, the State of California, the City of Chicago, and Air Canada, the BlueDot intelligence platform combines human and artificial intelligence to track emerging, endemic, and pandemic threats from infectious diseases and syndromes worldwide.

About RWDI and ParticleOne
Founded in 1972 in Guelph, Ontario, RWDI is a globally renowned environmental engineering firm, with 26 offices worldwide, tackling complex challenges in the built environment. Over the past five decades, the firm evolved from a respected Canadian company with deep technical expertise in wind engineering to a global firm known for solving some of the world’s most demanding building performance, climate engineering, and environmental challenges. RWDI launched ParticleOne, a cloud-based software platform built by its world-class building-performance engineers, scientists, and software developers, in response to the COVID-19 pandemic in 2020. Now enhanced by BlueDot infectious disease intelligence, ParticleOne measures and monitors the risk of outbreaks inside built structures by running thousands of simulations to develop customized mitigation strategies that match the specific profile of a space, including its use, and location. Currently deployed in hundreds of buildings in a variety of sectors, including commercial real estate, industry, and community spaces, ParticleOne guides building operators in making science-based decisions to protect both occupants and operations.

PreviousNext

SteraMist (Feb)

SteraMist (Feb)

News and Trends

  • RACE streamlines patient journey
  • Healthcare supply chain needs a re-think, observers say
  • EDI spots pricing anomalies in Ontario’s healthcare supply chain
  • AI centres of excellence and companies collaborate on apps
  • Talking Stick: New hope for Indigenous mental healthcare
More from the Print Edition

Subscribe

Subscribe

Free of charge to Canadian hospital managers and executives in nursing homes and home-care organizations. Learn More

Follow us on Social Media!

Follow us on Social Media!

Nihi Data [Winter 2023]

Nihi Data [Winter 2023]

WP

WP

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

Zebra

Zebra

CHT print-200×400

CHT print-200x400

SteraMist (Feb)

SteraMist (Feb)

Advertise with us

Advertise with us

Sectra One Cloud

Sectra One Cloud

Change Healthcare [2]

Change Healthcare [2]

Infoway [Feb2023]

Infoway [Feb2023]

Zebra

Zebra

CHT print-200×400

CHT print-200x400

Contact Us

Canadian Healthcare Technology
1118 Centre Street, Suite 207
Thornhill, Ontario, Canada L4J 7R9
Tel: 905-709-2330
Fax: 905-709-2258
info2@canhealth.com

  • Quick Links
    • Current Print Issue
    • Print Archive
    • Events
    • Vendors
    • About Us
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Resources
    • White Papers
    • Writers’ Guidelines
    • Privacy Policy
  • Topics
    • Administrative Solutions
    • Clinical Solutions
    • Companies
    • Continuing Care
    • Diagnostics
    • Education & Training
  •  
    • Electronic Records
    • Government & Policy
    • Infrastructure
    • Innovation
    • People
    • Privacy and Security

© 2023 Canadian Healthcare Technology

The content of Canadian Healthcare Technology is subject to copyright. Reproduction in whole or in part without prior written permission is strictly prohibited. Send all requests for permission to Jerry Zeidenberg, Publisher.

Search Site

Error: Enter a search term

  • Issues
    • Current Print Issue
    • Print Archive
  • Advertise
    • Publishing Schedule
    • Circulation
    • Unit Sizes and Rates
    • Mechanical Requirements
    • Electronic Advertising
    • White Papers
  • Subscribe
    • Print Edition
    • e-Messenger
    • White Papers
  • Events
  • Vendors
  • About Us